Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital

International Journal of Infectious Diseases

Volumn 17, Issue 4, 2013, Pages

  Sohn, Kyung Mok ^a   Peck, Kyong Ran ^b   Joo, Eun Jeong ^b   Ha, Young Eun ^b   Kang, Cheol In ^b   Chung, Doo Ryeon ^b   Lee, Nam Yong ^b   Song, Jae Hoon ^b  

^a Chungnam National University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Colonization; Enterococcus; Outpatient; Risk factors; Vancomycin resistance

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; DIALYSIS; FECES CULTURE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; NURSING HOME; OUTPATIENT DEPARTMENT; SURGERY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ENTEROCOCCUS; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PATIENT DISCHARGE; PROPORTIONAL HAZARDS MODELS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84875365336     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.09.019     Document Type: Article

References (42)

1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-85.
2. Hidron A.I., Edwards J.R., Patel J., Horan T.C., Sievert D.M., Pollock D.A., Fridkin S.K. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29:996-1011.
3. Lee K., Lee M.A., Lee C.H., Lee J., Roh K.H., Kim S., et al. Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007. Yonsei Med J 2010, 51:901-911.
4. Lee K., Jang S.J., Lee H.J., Ryoo N., Kim M., Hong S.G., Chong Y. Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001. J Korean Med Sci 2004, 19:8-14.
5. Song X., Srinivasan A., Plaut D., Perl T.M. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect Control Hosp Epidemiol 2003, 24:251-256.
6. Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003, 51(Suppl 3):iii13-iii21.
7. Muto C.A., Jernigan J.A., Ostrowsky B.E., Richet H.M., Jarvis W.R., Boyce J.M., Farr B.M. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003, 24:362-386.
8. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1995, 44:1-13. Centers for Disease Control and Prevention (CDC).
9. Martone W.J. Spread of vancomycin-resistant enterococci: why did it happen in the United States?. Infect Control Hosp Epidemiol 1998, 19:539-545.
10. Zirakzadeh A., Patel R. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc 2006, 81:529-536.
11. Muto C.A., Giannetta E.T., Durbin L.J., Simonton B.M., Farr B.M. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002, 23:429-435.
12. Puzniak L.A., Gillespie K.N., Leet T., Kollef M., Mundy L.M. A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price?. Infect Control Hosp Epidemiol 2004, 25:418-424.
13. Price C.S., Paule S., Noskin G.A., Peterson L.R. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis 2003, 37:921-928.
14. Mayhall C.G. Control of vancomycin-resistant enterococci: it is important, it is possible, and it is cost-effective. Infect Control Hosp Epidemiol 2002, 23:420-423.
15. Vergis E.N., Hayden M.K., Chow J.W., Snydman D.R., Zervos M.J., Linden P.K., et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study. Ann Intern Med 2001, 135:484-492.
16. Furtado G.H., Mendes R.E., Pignatari A.C., Wey S.B., Medeiros E.A. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies. Am J Infect Control 2006, 34:447-451.
17. Montecalvo M.A., de Lencastre H., Carraher M., Gedris C., Chung M., VanHorn K., Wormser G.P. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995, 16:680-685.
18. Byers K.E., Anglim A.M., Anneski C.J., Farr B.M. Duration of colonization with vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002, 23:207-211.
19. Pacio G.A., Visintainer P., Maguire G., Wormser G.P., Raffalli J., Montecalvo M.A. Natural history of colonization with vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant Gram-negative bacilli among long-term-care facility residents. Infect Control Hosp Epidemiol 2003, 24:246-250.
20. Bell J.M., Paton J.C., Turnidge J. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol 1998, 36:2187-2190.
21. Perichon B., Reynolds P., Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 1997, 41:2016-2018.
22. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1995, 44:1-13. Recommendations for preventing the spread of vancomycin resistance.
23. Harbarth S., Cosgrove S., Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 2002, 46:1619-1628.
24. Fridkin S.K., Edwards J.R., Courval J.M., Hill H., Tenover F.C., Lawton R., et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001, 135:175-183.
25. Elizaga M.L., Weinstein R.A., Hayden M.K. Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci. Clin Infect Dis 2002, 34:441-446.
26. Bonten M.J., Slaughter S., Ambergen A.W., Hayden M.K., van Voorhis J., Nathan C., Weinstein R.A. The role of " colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998, 158:1127-1132.
27. Ostrowsky B.E., Trick W.E., Sohn A.H., Quirk S.B., Holt S., Carson L.A., et al. Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 2001, 344:1427-1433.
28. Rao G.G., Ojo F., Kolokithas D. Vancomycin-resistant Gram-positive cocci: risk factors for faecal carriage. J Hosp Infect 1997, 35:63-69.
29. Yang K.S., Fong Y.T., Lee H.Y., Kurup A., Koh T.H., Koh D., Lim M.K. Predictors of vancomycin-resistant Enterococcus (VRE) carriage in the first major VRE outbreak in Singapore. Ann Acad Med Singapore 2007, 36:379-383.
30. Tornieporth N.G., Roberts R.B., John J., Hafner A., Riley L.W. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996, 23:767-772.
31. Zhou Q., Moore C., Eden S., Tong A., McGeer A. Factors associated with acquisition of vancomycin-resistant enterococci (VRE) in roommate contacts of patients colonized or infected with VRE in a tertiary care hospital. Infect Control Hosp Epidemiol 2008, 29:398-403.
32. Askarian M., Afkhamzadeh R., Monabbati A., Daxboeck F., Assadian O. Risk factors for rectal colonization with vancomycin-resistant enterococci in Shiraz, Iran. Int J Infect Dis 2008, 12:171-175.
33. Byers K.E., Anglim A.M., Anneski C.J., Germanson T.P., Gold H.S., Durbin L.J., et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001, 22:140-147.
34. Song J.Y., Cheong H.J., Jo Y.M., Choi W.S., Noh J.Y., Heo J.Y., et al. Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis. Am J Infect Control 2009, 37:734-740.
35. Benenson S., Cohen M.J., Block C., Stern S., Weiss Y., Moses A.E. Vancomycin-resistant enterococci in long-term care facilities. Infect Control Hosp Epidemiol 2009, 30:786-789.
36. Brennen C., Wagener M.M., Muder R.R. Vancomycin-resistant Enterococcus faecium in a long-term care facility. J Am Geriatr Soc 1998, 46:157-160.
37. Boyce J.M., Opal S.M., Chow J.W., Zervos M.J., Potter-Bynoe G., Sherman C.B., et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994, 32:1148-1153.
38. Weinstein J.W., Tallapragada S., Farrel P., Dembry L.M. Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci. J Clin Microbiol 1996, 34:210-212.
39. D'Agata E.M., Gautam S., Green W.K., Tang Y.W. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 2002, 34:167-172.
40. Huckabee C.M., Huskins W.C., Murray P.R. Predicting clearance of colonization with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus by use of weekly surveillance cultures. J Clin Microbiol 2009, 47:1229-1230.
41. Park I., Park R.W., Lim S.K., Lee W., Shin J.S., Yu S., et al. Rectal culture screening for vancomycin-resistant Enterococcus in chronic haemodialysis patients: false-negative rates and duration of colonisation. J Hosp Infect 2011, 79:147-150.
42. Song J.Y., Hwang I.S., Eom J.S., Cheong H.J., Bae W.K., Park Y.H., et al. Prevalence and molecular epidemiology of vancomycin-resistant enterococci (VRE) strains isolated from animals and humans in Korea. Korean J Intern Med 2005, 20:55-62.